Clinical Trial Update: Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage [Phase 2]

View source ↗

Summary

Phase 2 trial update on desmopressin for reversal of antiplatelet drugs in acute stroke with hemorrhage; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Acute

Drugs mentioned

• Desmopressin (Desmopressin)

Snippet

Sponsor: University of Nottingham | Conditions: Stroke, Acute | Phase 2 | Status: COMPLETED